Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Free Cash Flow (2009 - 2026)

Charles River Laboratories International (CRL) posted Free Cash Flow of $148.6 million for Q2 2026, up 1102.09% on a QoQ basis from -$14.8 million in Q1 2026, and down 12.22% year-over-year from $169.3 million in Q2 2025.

Analysis

Charles River Laboratories International (CRL) Free Cash Flow (2009 - 2026) Analysis & Trends

Charles River Laboratories International has reported Free Cash Flow for 18 years, with the latest figure at $148.6 million in Q2 2026.

  • On a quarterly basis, Free Cash Flow fell 12.22% year-over-year to $148.6 million in Q2 2026; TTM through Jun 2026 was $370.6 million, a 35.94% decrease from a year earlier, with the FY2025 full-year figure at $518.5 million, up 3.37% from the prior year.
  • Free Cash Flow was $148.6 million for Q2 2026 at Charles River Laboratories International, up from -$14.8 million in the prior quarter.
  • The five-year high for Free Cash Flow was $213.1 million in Q3 2024, with the low at -$14.8 million in Q1 2026.
  • Average Free Cash Flow over 5 years is $100.8 million, with a median of $98.1 million recorded in 2024.
  • The sharpest annual moves came in 2024 and 2026: Free Cash Flow soared 1923.29% in 2024, then sank 113.2% in 2026.
  • Over 5 years, Free Cash Flow stood at $145.7 million in 2022, then retreated by 2.14% to $142.6 million in 2023, then sank by 41.28% to $83.7 million in 2024, then sank by 30.06% to $58.6 million in 2025, then surged by 153.75% to $148.6 million in 2026.
  • The last three Free Cash Flow figures came in at $148.6 million (Q2 2026), -$14.8 million (Q1 2026), and $58.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 360.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 138.10 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 323.69 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 148.62 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 19.90 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -46.89 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -617,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -2.84 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -3.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 148.62 Mn
Mar 28, 2026 -14.83 Mn
Dec 27, 2025 58.57 Mn
Sep 27, 2025 178.25 Mn
Jun 28, 2025 169.31 Mn
Mar 29, 2025 112.37 Mn
Dec 28, 2024 83.75 Mn
Sep 28, 2024 213.07 Mn
Jun 29, 2024 154.05 Mn
Mar 30, 2024 50.74 Mn
Dec 30, 2023 142.62 Mn
Sep 30, 2023 139.50 Mn
Jul 1, 2023 80.74 Mn
Apr 1, 2023 2.51 Mn
Dec 31, 2022 145.73 Mn
Sep 24, 2022 60.39 Mn
Jun 25, 2022 66.62 Mn
Mar 26, 2022 22.17 Mn
Dec 25, 2021 130.48 Mn
Sep 25, 2021 119.19 Mn